Perspectives

1:30
What to look out for at ASH: focus on MPNs
Ruben Mesa
1:51
Improving outcomes for myelofibrosis
Ruben Mesa
1:38
Cord vs. haplo in SAA
Rainer Storb
3:15
Is haploidentical the best curative option for sickle cell disease?
Miguel Abboud
1:01
Treating and diagnosing CLL in India
Abraham Varghese
2:05
What role could genomics play in oncology?
Richard Rosenquist
2:00
Young Investigator Meeting at iwCLL 2019
Talha Munir
2:19
CARs: driving the field forward
Michael Bishop
2:12
Philip McCarthy: COSTEM highlights
Philip McCarthy
1:54
The importance of COSTEM: meeting highlights & summary
Arnon Nagler
2:29
Arnon Nagler votes haploidentical
Arnon Nagler
1:20
The evolution of COSTEM
Nicolaus Kröger
2:26
TMA; approaching this rare condition
Charles Craddock
3:03
Improving AML outcomes
Charles Craddock
1:14
NCRI UK update
Charles Craddock
2:01
The Chinese CAR-T experience
Peihua Lu
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals